The Rich Domestic Demand Growth Hybrid Securities Investment Fund (abbreviation: Rich Domestic Demand Growth Hybrid C, code 013045) announced its latest net value on April 8, up 3.04%.
Established on July 16, 2021, the performance comparison benchmark is the return of the CSI 300 Index ×65% + the yield of the Hang Seng Index (converted using the valuation exchange rate) ×15% + the yield of the China Bond Composite Full Price Index ×20%. The fund has returned -31.73% since its inception, 0.24% this year, -3.82% over the past month, -0.45% over the past year, and -11.25% over the last three years. In the past year, the fund ranked 4730/7812 in its peer group.
The fund manager is Wang Yuanyuan. Wang Yuanyuan has managed (or intends to manage) the fund since July 16, 2021, with a return of -31.73% during his tenure.
According to the latest periodic report, the fund's top 10 heavy stocks are as follows:
| stock symbol | ,stock name | ,position ratio | , number of shares held (shares). | Market value of the position (RMB). |
| 600600 | Tsingtao Beer | 8.15% | 1426231 | 115 million |
| 600519 | Kweichow Moutai | 6.77% | 62886 | 95.8383 million |
| 688169 | Roborock | 6.55% | 423156 | 92.7939 million |
| 688617 | Huitai Medical | 5.07% | 192840 | 71.8001 million |
| 300832 | new industry | 4.49% | 897256 | 63.5706 million |
| 603997 | Jifeng shares | 3.52% | 4355354 | 49.8688 million |
| 09992 | Bubble Mart | 3.13% | 533844 | 44.3195 million |
| 300750 | CATL | 2.86% | 152140 | 40.4692 million |
| 000858 | Wuliangye | 2.85%, | 288040 | 40.3371 million |
| 688271 | United Imaging Medical | 2.76% | 309123 | 39.0731 million |
Ticker Name
Percentage Change
Inclusion Date
